SAVING LIMBS, SAVING LIVES

Monday, November 3, 2025

1:45pm - 2:30pm PT

Moderator(s)

Joshua Beckman, MD

Chief, Division of Vascular Medicine
UT Southwestern Medical Center
Vascular Medicine
Dallas, Texas, United States

Disclosure(s): Janacare: Stockholder - Privately-held company
Medtronic: Consultant
Merck: Consultant
Novartis: Consultant
Novo Nordisk: Consultant
Regeneron: Consultant
tourmaline: Consultant

Panel(s)

Herbert Aronow, MD, MPH

Medical Director, Heart & Vascular Services
Henry Ford Health
Interventional Cardiology
Detroit, Michigan, United States

Disclosure(s): Amplitude Vascular Systems: Consultant
Medtronic: Advisory Board; Consultant
Philips: Consultant
RapidAI: Consultant
Recor Medical: Advisory Board; Consultant
Silk Road: Consultant
Marc Bonaca, MD, MPH

Professor
University of Colorado
Vascular Medicine
Aurora, Colorado, United States

Disclosure(s): 35Pharma, Inc.; Abbott Labratories; Agios Pharmaceuticals, Inc.; Alexion Pharmaceuticals; Amgen; Anthos Therapeutics, Inc.; Arrowhead Pharmaceuticals; Autonomy Bio, Inc.; Bayer; Bristol-Myers Squibb; Cleerly, Inc.; Cook Regentec: Grants/Research Support Recipient
Eidos Therapeutics, Inc.; EluraBio, Inc.; Esperion Therapeutics, Inc.; Faraday Pharmaceuticals, Inc.; Gasherbrum Bio, Inc.; Insmed; IsomAb Limited; JanOne Biotech Holdings, Inc.; Janssen Pharmaceuticals, Inc.; Lexicon Pharmaceuticals, Inc.: Grants/Research Support Recipient
Lilly USA; Medison Pharma; Merck Sharp & Dohme Corp.; Nectero Medical, Inc.; NewAmsterdam Pharma; Novartis Pharmaceuticals; Novo Nordisk, Inc.; Pfizer; Piper Sandler & Co; PPD Development; Prothena Biosciences; Sanofi; Silence Therapeutics: Grants/Research Support Recipient
Stealth BioTherapeutic, Inc.; Regeneron; Tourmaline Bio, Inc.; VarmX; Verve Therapeutics: Grants/Research Support Recipient
Foluso Fakorede, MD

MD/CEO Cardiovascular Solutions of Central Mississippi/Fusion Vascular
Cardiovascular Solutions of Central Mississippi
Interventional Cardiology
Cleveland, Mississippi, United States

Disclosure(s): No financial relationships to disclose
Elsie Ross, MD, MSc

Associate Professor of Surgery
University of California, San Diego
Vascular Surgery
La Jolla, California, United States

Disclosure(s): Cook Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Novartis: Advisory Board; Consultant
Steven Kum, MD

Consultant Vascular Surgeon
Mount Elizabeth Novena Hospital / Changi General Hospital
Vascular Surgery
Singapore, Singapore

Disclosure(s): Boston Scientific: Advisory Board; Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
Cagent Vascular: Consultant
LimFlow: Consultant
Orbus Neeich: Consultant

Presentations:

1:45pm - 1:52pm PT

Update on the AHA/ACC Guidelines in CLTI Patients
Speaker: Herbert Aronow, MD, MPH – Henry Ford Health
1:52pm - 1:56pm PT

Panel Discussion
1:56pm - 2:03pm PT

What Is Enough for CLTI? When to Hold 'Em and When to Fold ‘Em During the Procedure
Speaker: Steven Kum, MD – Mount Elizabeth Novena Hospital / Changi General Hospital
2:03pm - 2:07pm PT

Panel Discussion
2:07pm - 2:14pm PT

How Best to Manage and Prevent Recrudescence in CLTI
Speaker: Elsie Ross, MD, MSc – University of California, San Diego
2:14pm - 2:18pm PT

Panel Discussion
2:18pm - 2:25pm PT

Beyond Revascularization: Cardiovascular Risk Reductions for CLTI Patients
Speaker: Marc P. Bonaca, MD, MPH – University of Colorado
2:25pm - 2:30pm PT

Panel Discussion